Indy
Menu ☰
Datasets
Insider Transactions Congress Trades
Hubs
Politicians Hub Tickers Hub
Leaderboards News
Sign in Register

Market News

Stocks Press Releases Crypto Forex

Big Banks Are Setting the Tone as Earnings Season Kicks Off

Auto parts lender First Brands filed for Chapter 11 bankruptcy protection with around $6.1 billion in debt on its books, while Tricolor—a subprime auto lender and dealer—filed for Chapter 7 bankruptcy citing alleged systemic fraud.

JPM marketbeat.com • Oct. 25, 2025

QUANTUM CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Quantum Investors of the November 3rd Deadline and Urges Investors to Contact the Firm

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Quantum (QMCO) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in  Quantum between November 15, 2024, and August 18, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

QMCO globenewswire.com • Oct. 25, 2025

Retire On Income: Revealing 2 Of My Holdings Up To 9% Cash Per Year

Valuation is circumstantial—your retirement income shouldn't be. Markets can take your gains anytime. But they can't take back the dividends already paid out. Recurring income is key to retirement confidence; check out our top picks with up to 9% yields.

CIM seekingalpha.com • Oct. 25, 2025

Medicus Pharma CEO discusses latest skin cancer trial milestone - ICYMI

Medicus Pharma (NASDAQ:MDCX) CEO Raza Bokhari talked with Proactive about the company's latest milestone in its ongoing Phase 2 clinical trial for a novel, noninvasive treatment for non-melanoma skin cancer. Bokhari shared that Medicus Pharma has now treated its first patient outside the United States, at the Cleveland Clinic Abu Dhabi, expanding the study into an international trial.

MDCX proactiveinvestors.com • Oct. 25, 2025

HIVE Digital Technologies' Frank Holmes outlines Bitcoin, AI revenue vision for 2026 - ICYMI

HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) executive chairman Frank Holmes talked with Proactive about the company's 100MW hydro expansion in Paraguay and its broader strategy to scale Bitcoin mining and AI infrastructure. Holmes explained that the new capacity will help push HIVE's mining power to 35 Exahash by 2026, representing close to 3% of the global Bitcoin network.

HIVE proactiveinvestors.com • Oct. 25, 2025

Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX

NEW YORK , Oct. 25, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting from allegations that Telix may have issued materially misleading business information to the investing public.

TLX prnewswire.com • Oct. 25, 2025

Intesa: Not Much Value Beyond Its 6.2% Dividend Yield

Intesa Sanpaolo has delivered strong returns, outperforming the market with robust earnings and a resilient business model. ISNPY's revenue growth is muted as lower ECB rates pressure net interest income, but cost control and diversification support profitability. The bank maintains high profitability and a strong capital position, enabling a 6.2% dividend yield, though this is lower than historical levels.

ISNPY seekingalpha.com • Oct. 25, 2025

Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA® (vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non-Erosive Reflux Disease

FLORHAM PARK, N.J., Oct. 25, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that results of additional analyses from its pivotal Phase 3 pHalcon-NERD-301 trial evaluating VOQUEZNA® (vonoprazan) tablets in patients with Non-Erosive Reflux Disease (NERD) have been published in the American Journal of Gastroenterology. The article, titled “Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Non-Erosive Reflux Disease”, underscores the significant burden of nighttime GERD symptoms and the potential role of VOQUEZNA in addressing this aspect of the disease.

NERD globenewswire.com • Oct. 25, 2025

Microsoft AI Joins Congress as Lawmakers Sell Stock

Microsoft Corporation's NASDAQ: MSFT AI assistant, Copilot, officially joined the congressional staff this fall. House offices have been authorized to tap Copilot's powers to “better serve constituents and streamline workflows.

MSFT marketbeat.com • Oct. 25, 2025

ROSEN, A HIGHLY RANKED LAW FIRM, Encourages V.F. Corporation Investors to Secure Counsel Before Important Deadline in Securities Fraud Lawsuit – VFC

NEW YORK, Oct. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of V.F. Corporation (NYSE: VFC) between October 30, 2023 and May 20, 2025, both dates inclusive (the “Class Period”), of the important November 12, 2025 lead plaintiff deadline.

LAW globenewswire.com • Oct. 25, 2025

Dividends Under $25: Don't Miss This 4.5% High-Yield Stock

If you're comfortable with bottom-fishing (or even catching falling knives) to get a high-yielding dividend stock alongside outsized turnaround potential, there are plenty of names that have fallen well below the $20 per-share mark to consider nibbling away at in the fourth quarter.

T 247wallst.com • Oct. 25, 2025

PennantPark Floating Rate Capital: I'm Buying This ~13% Yield Now

PennantPark Floating Rate Capital trades at a steep discount (P/NAV 0.77x) with a 13.7% yield, reflecting sector-wide pressures. PFLT's focus on the core middle market allows for higher spreads and lower risk compared to upper-middle-market BDC peers (ARCC, BXSL). Despite likely dividend cuts, PFLT offers attractive, de-risked income and potential for price recovery as sector sentiment improves.

PFLT seekingalpha.com • Oct. 25, 2025

SCHZ: A Modest Bet On Lower Rates Is Reasonable

Schwab U.S. Aggregate Bond ETF offers low fees, broad investment-grade exposure, and intermediate duration, making it a solid long-term diversifier. SCHZ has outperformed long-duration peers like TLT with lower volatility, but current conditions favor even shorter-duration instruments such as CLIP. Despite intermediate bonds' advantages, short-duration ETFs like CLIP offer similar yields with less risk in the current rate environment.

SCHZ seekingalpha.com • Oct. 25, 2025

Rental Properties Are Overrated - REITs Are The Real Opportunity

Rental properties are often pitched by online course-selling influencers as highly rewarding investments with passive income and low risk. I strongly disagree. I think it's the opposite. I explain why rentals are bad investments in most cases and how investors can earn better returns investing in REITs.

EPRT seekingalpha.com • Oct. 25, 2025

Super Micro Computer: Don't Let The Bears Fool You This Time

Super Micro Computer, Inc. remains a leading contender in the multi-year AI infrastructure buildout despite what appears to be a disappointing preliminary earnings release. SMCI maintains confidence in its $33B full-year revenue outlook, supported by a robust $12B design win pipeline and strong secular AI CapEx demand cadence. Recent SMCI price action shows a resilient bullish narrative and robust dip-buying, with technicals indicating buyers are absorbing volatility rather than panicking.

SMCI seekingalpha.com • Oct. 25, 2025
← Previous
Next →